Tendersinfo Gulf

Filter Search

Healthcare and Medical

Location Summary Deadline
Germany Conclusion Of A Non-exclusive Discount Agreement According To § 130a Abs. 8 Sgb V For The Active Ingredient Peginterferon Beta-1a For The Period From 01.01.2026 To 31.12.2027. Peginterferon Beta-1a 2026-05-16
Germany Conclusion Of A Non-exclusive Discount Agreement According To § 130a Abs. 8 Sgb V For The Active Ingredient Guanfacin For The Period 01.01.2026 - 31.12.2027 (plus Extension Option 1x12 Months). Guanfacin 2026-05-16
Germany Conclusion Of A Non-exclusive Discount Agreement In Accordance With Section 130a Paragraph 8 Sgb V For The Active Ingredient Lebrikizumab, Atc D11ah10 For The Period January 1st, 2026 - December 31st, 2027 2026-05-16
Germany Conclusion Of A Non-exclusive Discount Agreement In Accordance With Section 130a Paragraph 8 Sgb V For The Active Ingredient Tildrakizumab, Atc L04ac17 For The Period January 1st, 2026 - December 31st, 2027 2026-05-16
Germany Open House Drug Discount Agreements For The Active Ingredient Ranibizumab, As A Pre-filled Syringe, Atc S01la04 2026-05-16
Germany Open House Discount Contracts 2025-15 2026-05-16
Germany Pharmaceutical Discount Contracts According To § 130a Abs. 8 Sgb V Within The Framework Of Open-house Procedures Vgv Tender Ikk Classic. Pharmaceuticals 2026-05-16
Germany Open House Drug Discount Agreements Pazopanib, Atc L01ex03 2026-05-16
Germany Open House Procedure - Outpatient Venous Therapy 2026-05-16
Germany Open House Drug Discount Agreements For The Active Ingredients Formoterol, Glycopyrronium Bromide And Beclometasone, Atc R03al09 2026-05-16
Whats app